HIV regulatory and accessory gene mRNAs. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HIV regulatory and accessory gene mRNAs.

Annu Conf Australas Soc HIV Med. 1993 Oct 28-30;5:108 (poster no. 66). Unique Identifier : AIDSLINE ASHM5/94348926
Smith J; Penschow J; Deacon NJ; AIDS Molecular Biology Lab, Macfarlane Burnet Centre for Medical; Research, Fairfield, Vic.


Abstract: The regulatory and accessory proteins of human immunodeficiency virus type 1 (HIV-1) are produced from singly or multiply spliced mRNAs. We have used HIV-1 specific oligonucleotide primer pairs in a polymerase chain reaction procedure on cDNA reverse transcribed from cytoplasmic RNA extracted from lymphocytic cell lines infected with HIV-1 228200. The amplified products were analysed by hybridisation with spliced junction-specific oligonucleotide probes to determine splice donor/splice acceptor combination utilisation and the temporal expression of different mRNA species. This work has led to the identification of two novel splice acceptor sites which are used in the early production of a series of distinct RNAs upon acute infection. These RNAs have also been demonstrated in infected cells by in-situ hybridisation with the splice junction specific probes. Work is currently being carried out to determine the function of these RNAs.
Keywords: Cell Line, Transformed Genes, Regulator/*GENETICS Human HIV-1/*GENETICS In Situ Hybridization RNA Probes RNA Splicing/*GENETICS RNA, Messenger/*GENETICS ABSTRACTKWDcellline,transformedgenes,regulator/KWDgeneticshumanhiv-1/KWDgeneticsinsituhybridizationrnaprobesrnasplicing/KWDgeneticsrna,messenger/KWDgeneticsabstract
941230
M94C4301

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .